AVROBIO Inc. is a leading clinical-stage gene therapy company focused on developing potentially life-changing treatments for patients with rare genetic diseases. With a strong pipeline and a skilled team, AVROBIO is at the forefront of the rapidly evolving field of gene therapy.
